Latest News

  • Industry Objects To CMS Guidance On NGS Testing

    Diagnostics World Brief  Members of 63 leading health care companies and organizations representing patients, providers, academic medical centers, laboratories, and diagnostic manufacturers urged the Centers for Medicare and Medicaid Services (CMS) to revise its interpretation of the National Coverage Determination (NCD) for Next Generation Sequencing (NGS). In a letter to CMS Administrator Seema Verma, the organizations expressed serious concerns that the overly broad interpretation will restrict patient access to medically necessary and relevant clinical tests and adversely impact cancer care and outcomes.

    Feb 1, 2019
  • Rapid Response And The Outbreaks To Come

    Diagnostics World | According to the director of the Point-of-Care Testing Center for Teaching and Research at the UC Davis Health System, we should be asking ourselves why we have not reached out and teamed up with the public health profession in America to educate and get ready for outbreaks in our communities by enabling everyone with point-of-care testing.

    Feb 1, 2019
  • OpGen Joins New York On Statewide Antimicrobial Resistance Tracking Plan

    Diagnostics World | These days, OpGen is focused on combating the global rise of antibiotic resistant pathogens. The company, which has a long history in sequencing technology, is now focused tightly on genes that confer antimicrobial resistance.

    Jan 31, 2019
  • New Saliva Glucose Unit Pairs Biosensor, App For Painless Testing

    Diagnostics World Brief | The iQ Group Global today introduced the Saliva Glucose Biosensor, the world’s first saliva-based glucose test for diabetes management that measures glucose in saliva rather than blood.

    Jan 31, 2019
  • Biocare, First Light Diagnostics, Ghana, And More: News From January 2019

    Diagnostics World | January featured news, products, and partnerships from around the diagnostics community from numerous companies, universities, and organizations, including Biocare, First Light Diagnostics, the government of Ghana, and more.

    Jan 30, 2019
  • Could A Liquid Biopsy & AI Combo Cure Cancer? Some Think It’s Worth Finding Out

    Diagnostics World | As cancer continues to claim lives and ring up cash registers along the way, it’s no wonder scientists continue to search for clever ways to battle back. Liquid biopsies, with a combination of AI, are one approach gaining attention and traction thanks in part to their ability to test patients multiple times in less invasive ways than traditional approaches.

    Jan 29, 2019
  • Quake Lab Utilizes RNA Sequencing Tool For Food Allergy Diagnostics

    Diagnostics World | Researchers in the Stanford lab of Stephen Quake are using single cell RNA sequencing in an effort to provide insight into food allergies and the antibodies that cause them.

    Jan 24, 2019
  • Genoox Announces Automated Genomic Reanalysis, Scripps User Notes

    Diagnostics World | Genoox today announces artificial intelligence-based tools for regular and periodic genomic data reanalysis. Scripps users weigh in on the platform.

    Jan 24, 2019
  • Color Genomics Improves Genetic Testing Efficiency With Illumina, Slack Partnerships

    Diagnostics World | With recent partnerships with Illumina, cloud-based communication provider Slack, and other organizations, Color Genomics is looking to progress their genetic testing portfolio.

    Jan 21, 2019
  • Obtaining Diagnostic Test Reimbursement In The Age Of Evidence

    Diagnostics World Contributed Commentary | The biggest challenge that most diagnostics companies face in commercializing their tests is getting Medicare and private health insurers to pay for them. With the healthcare industry’s growing focus on improving the quality of healthcare and reducing costs, this struggle has become even more intense in recent years.

    Jan 11, 2019
  • Next-Gen Phenotyping Through AI Beats Clinician Diagnoses

    Diagnostics World | Diagnostics holds many opportunities for artificial intelligence, and FDNA has been training its machine learning algorithm to scan photographs to propose diagnoses for genetic syndromes.

    Jan 7, 2019
  • Veracyte, Johnson & Johnson Enter Lung Cancer Diagnostic Collaboration

    Diagnostics World Brief | Veracyte has entered into a long-term strategic collaboration with Johnson & Johnson Innovation and the Lung Cancer Initiative at Johnson & Johnson to advance the development and commercialization of novel diagnostic tests to detect lung cancer at its earliest stages, when the disease is most treatable. Veracyte announced the collaboration yesterday.

    Jan 4, 2019
  • Top 10 Stories Of 2018: FDA In Vitro Guidances, Flu Detection, And More

    Diagnostics World | As we head into 2019, we at Diagnostics World would like to take a moment and reflect on the groundbreaking achievements from this past year. In that spirit, here are the top 10 stories of 2018.

    Jan 2, 2019
  • IBM Wants Doctors To Use This Tiny Fingernail Sensor To Track Diseases

    Fast Company | IBM has created a tiny sensor that attaches to your fingernail and monitors things like pressure, motion, and grip strength. The tiny sensor can monitor cardiovascular health.

    Dec 21, 2018